1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow SKLB1028: new trials by email Literature Review of SKLB1028 trials Research Report on SKLB1028
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients SKLB1028 150mg bid, SKLB1028 200mg bid, SKLB1028 300mg qd - Acute Myeloid Leukemia | Phase 2 | Unknown | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 30 | 2019-07-01 | 2019-07-16 |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1)
China (1)